Aurora Cannabis logo

Aurora Cannabis ACB

$ 5.85 -0.26%

Annual report 2024
added 02-15-2025

report update icon

Country

-

IPO year

2018

Industry

Drug manufacturers

Stock Exchange

NYSE

CEO

Mr. Michael Singer

Employees in the company

2 731

Shares

-

Market Cap[1]

$ 86.3 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

Issuer Price % 24h Market Cap Exchange Country
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
$ 29.44 -1.04 % $ 951 M Nasdaq Global Select Market usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
$ 14.7 - $ 621 M Nasdaq Global Select Market britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
$ 15.25 - $ 754 M Nasdaq Global Market,SPB usaUSA
PetIQ PetIQ
PETQ
$ 13.6 1.64 % $ 400 M Nasdaq Global Select Market,SPB usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
$ 0.6 10.11 % $ 58.2 M Nasdaq Capital Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
$ 0.173 -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Recro Pharma Recro Pharma
REPH
$ 1.4 -4.76 % $ 65.3 M Nasdaq Global Select Market usaUSA
Athenex Athenex
ATNX
$ 0.2 -23.39 % $ 1.76 M Nasdaq Global Select Market usaUSA
PLx Pharma PLx Pharma
PLXP
$ 0.09 -27.8 % $ 2.56 M Nasdaq Capital Market usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
$ 11.09 -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
$ 1.81 -4.74 % $ 281 M Nasdaq Global Select Market usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
$ 3.23 -4.59 % $ 424 M Nasdaq Capital Market usaUSA
Lannett Company Lannett Company
LCI
$ 0.66 1.15 % $ 7.11 M NYSE usaUSA
DURECT Corporation DURECT Corporation
DRRX
$ 0.78 -3.16 % $ 20.5 M Nasdaq Capital Market usaUSA
Biogen Biogen
BIIB
$ 141.07 2.91 % $ 20.5 B Nasdaq Global Select Market,SPB usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
$ 40.0 -0.1 % $ 2.03 B Nasdaq Global Select Market schwedenSchweden
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
$ 218.96 - $ 6.81 B Nasdaq Global Select Market britainBritain
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
$ 8.22 - $ 376 M Nasdaq Global Market usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
$ 9.12 - $ 459 M Nasdaq Global Market usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
$ 2.41 -0.27 % $ 21.9 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.